Covered recipient · General Payments record
ERIK M DEJONGHE
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$4,673.82
- Reported across 256 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $719.48 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $366.51 | 18 |
| GENZYME CORPORATION | $109.95 | 4 |
| Lilly USA, LLC | $72.61 | 3 |
| PFIZER INC. | $43.68 | 3 |
| Celgene Corporation | $38.44 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.96 | 1 |
| Madrigal Pharmaceuticals | $17.99 | 1 |
| Janssen Biotech, Inc. | $17.76 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $16.94 | 1 |
| Braintree Laboratories, Inc. | $13.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.05 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613538 | CMS |
| ABBVIE INC. | $24.32 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613540 | CMS |
| ABBVIE INC. | $22.24 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613542 | CMS |
| ABBVIE INC. | $23.24 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613544 | CMS |
| ABBVIE INC. | $19.26 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613546 | CMS |
| ABBVIE INC. | $19.35 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613548 | CMS |
| ABBVIE INC. | $27.46 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613550 | CMS |
| ABBVIE INC. | $22.01 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613552 | CMS |
| ABBVIE INC. | $19.44 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613554 | CMS |
| ABBVIE INC. | $19.87 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613556 | CMS |
| ABBVIE INC. | $17.95 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613558 | CMS |
| ABBVIE INC. | $28.89 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613560 | CMS |
| ABBVIE INC. | $20.86 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613562 | CMS |
| ABBVIE INC. | $24.27 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613564 | CMS |
| ABBVIE INC. | $17.87 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613566 | CMS |
| ABBVIE INC. | $16.24 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613568 | CMS |
| ABBVIE INC. | $10.41 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613570 | CMS |
| ABBVIE INC. | $13.78 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103613572 | CMS |
| Braintree Laboratories, Inc. | $13.64 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125513909 | CMS |
| Celgene Corporation | $22.18 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101165038 | CMS |
| Celgene Corporation | $16.26 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101165040 | CMS |
| GENZYME CORPORATION | $30.56 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976331 | CMS |
| GENZYME CORPORATION | $38.23 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976343 | CMS |
| GENZYME CORPORATION | $17.50 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976349 | CMS |
| GENZYME CORPORATION | $23.66 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976355 | CMS |
| Intercept Pharmaceuticals, Inc. | $16.94 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113633414 | CMS |
| Janssen Biotech, Inc. | $17.76 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078397441 | CMS |
| Lilly USA, LLC | $20.76 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134974109 | CMS |
| Lilly USA, LLC | $28.94 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136169067 | CMS |
| Lilly USA, LLC | $22.91 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136170375 | CMS |
| Madrigal Pharmaceuticals | $17.99 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144164281 | CMS |
| PFIZER INC. | $15.56 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131546783 | CMS |
| PFIZER INC. | $14.05 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131454143 | CMS |
| PFIZER INC. | $14.07 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131535615 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.96 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137526182 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.